Breathe Well Live Well
Lung Disease News |
New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in US
Lung Disease News Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food and Drug … SPIRIVA® RESPIMAT® Now Available in the US for Maintenance Treatment of Asthma in Adults and Adolescents |
View full post on asthma – Google News
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: AZD7594 inhalation powder (200 ?g); Drug: AZD7594 inhalation powder (400 ?g); Drug: AZD7594 pressurized inhalation suspension (200 ?g); Drug: AZD7594 placebo inhalation powder; Drug: AZD7594 placebo pressurized inhalation suspension
Sponsor: AstraZeneca
Not yet recruiting – verified December 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: beclomethasone; Drug: fluticasone
Sponsor: University of Virginia
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Conditions: Asthma (Part 1); COPD (Part 2)
Interventions: Drug: Dose 1, AZD8871 50 ?g (Part 1); Drug: Dose 2, AZD8871 100 ?g (Part 1); Drug: Dose 3, AZD8871 300 ?g (Part 1); Drug: Dose 4, AZD8871 600 µg (Part 1); Drug: Dose 5, AZD8871 1200 µg (Part 1); Drug: Dose 6, AZD8871 1800 ?g (Part 1); Drug: Placebo, AZD8871 placebo (Part 1); Drug: Treatment A, AZD8871 dose A (Part 2); Drug: Treatment B, AZD8871 dose B (Part 2); Drug: Treatment C, Indacaterol 150 ?g (Part 2); Drug: Treatment D, Tiotropium 18 ?g (Part 2)
Sponsor: AstraZeneca
Not yet recruiting – verified October 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Positive Data Presented on Pieris Pharmaceuticals' Inhaled Asthma Program at …
Benzinga Prior to joining Pieris Dr. Fitzgerald held senior positions at Argenta Discovery and Pulmagen Therapeutics, where she was responsible for clinical development of inhaled and oral drug candidates for both COPD and asthma. Previously, she was employed … |
View full post on asthma – Google News
|
New inhaled drugs in wings for asthma
BDlive A NEW inhaled medication, quilizumab, geared towards treating mild asthma and allergies by interrupting the production of an immune system protein that triggers allergic reactions, was recently reported on in Science Translational Medicine. The … |
View full post on asthma – Google News
Lung Disease News |
Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma
Lung Disease News Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as a … |
View full post on asthma – Google News
|
Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung …
Lung Disease News GSK Expands Its COPD And Asthma Portfolio Across The US. Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled … |
View full post on asthma – Google News
|
Inhaled Steroids Exacerbate Pollution's Effect on Asthma
Medscape Inhaled corticosteroids cannot adequately protect children with asthma from high levels of air pollution and may actually exacerbate the effects of pollutants, caution investigators in a clinical study. The authors found that both long-term and short … |
View full post on asthma – Google News
|
Inhaled Steroids Exacerbate Pollution's Effect on Asthma – Medscape
Medscape Inhaled corticosteroids cannot adequately protect children with asthma from high levels of air pollution and may actually exacerbate the effects of pollutants, caution investigators in a clinical study. The authors found that both long-term and short … |
View full post on asthma – Google News